Abstract:Objective To evaluate the safety and efficacy of transcatheter closure of post-surgery residual ventricular septal defect( VSD)and its mid-to long-term follow-up results. Methods The clinical data of patients with post-surgery residual VSD who underwent an attempt of percutaneous device closure from September 2002 to December 2013 in Childrenˊs Hospital of Fudan University were summarized. Results 21 patients( 11 males and 10 females ) with post-surgery residual VSD underwent an attempt of percutaneous device closure in our center. The mean age was 8. 8 years(2. 7-21 years)and the mean weight was 26. 3 kg(10. 5-53. 5 kg). Among these 21 patients,their previous surgery procedures were VSD repair in 13 cases,repair of tetralogy of Fallot( TOF)in 5 cases,repair of double outlet right ventricle( DORV)in 2 cases,and repair of complete transposition of great arteries( TGA)with VSD in 1 case. In addition,1 patient of post-TOF repair was associated with frequently premature ventricular contraction and ventricular tachycardia,2 patients of post VSD repair were associated with recoarctation of the aorta. The duration between previous surgery and transcathter device closure was 11-80 months. The mean diameter of VSDs in right ventricle( RV) side was 3. 73 mm(1. 6-6. 3 mm)by angiogram. There were multiple shunts in RV side in 4 patients,and one patient was left ventricle to right atrium shunt. The Qp/Qs ratio was 1. 53 ± 0. 23,and there was no pulmonary hypertension more than moderate. Amplatzer devices were successfully deployed in all cases except for 1 failure case due to a repeat complete block during the arterial-venous loop establishing,and 2 devices were used in 1 patient. The median device size was 6. 5 mm(4 -12 mm). A radio-frequency ablation and 2 balloon dilatations were successfully finished for the associated defects in the same procedure. There was no procedure-related adverse events. Mild residual shunt was showed by angiogram and transthoracic echocardiography( TTE ) immediate after closure in 3 patients. Three patients with moderate to severe tricuspid regurgitation before device closure improved significantly after closure. All patients were doing well clinically in a mean 22. 2 months(1 - 79 months)follow up. Minor arrhythmia was observed in 2 patients in the first year follow-up ECG including incomplete right bundle branch and first-degree atrioventricular block,and remained the same in another 6 months to 1 year follow-up. All 3 residual shunts disappeared in the follow-up echocardiography except for a 3. 4 mm residual shunt still existed in 1 patient with normal heart size and function. No new onset tricuspid or aortic regurgitation was showed. There was no device malposition or embolization,or thrombosis formation. Conclusion Transcatheter closure of post-surgery residual ventricular septal defect is safe,effective and less trauma. The mid-to long-term follow-up results of these cases are promising.

Analysis of efficacy associated with multiple malformations of congenital heart diseases treated with simultaneous transcatheter therapy

[Transcatheter therapy of combined congenital heart diseases in children].

Non-fluoroscopic percutaneous transcatheter closure of atrial septal defects in children under transesophageal echocardiographic guidance

Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

Surgical treatment of 275 cases with complete transposition of the great arteries

Application of Transesophageal Echocardiography in High Ventricular Septal Defect Closure Via the Small Intercostal Incision with Eccentric Occluder in Children

Simultaneous minimally invasive technique for congenital heart disease and pectus excavatum

Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

Nine Cases of Children with Ventricular Septal Defect Performed Super Minimally Invasive Trans Intercostal Device Closure

[Transesophageal Echocardiography-Guided Hybrid Therapy for Ventricular Septal Defects in Children].

Transcatheter Closure of Secundum Atrial Septal Defect with Amplatzer Occluder Device

Clinical Analysis of Surgical Treatment for 189 Infants with Ventricular Septal Defect

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Simultaneous Transcatheter Closure of a Ventricular Septal Defect and Pulmonary Valvuloplasty: A Case Report

Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect in Children Using Symmetric Occluders: an 8-Year Multiinstitutional Experience.

The efficacy and its mid-to long-term follow-up of transcathter closure of post-surgery residual ventricular septal defect of congenital heart disease

Transthoracic Echocardiographic Value in Transcatheter Closure of Perimembranous Ventricular Septal Defect Using Amplatzer Occluder

Value of Echocardiography for Transcatheter Closure of Multiple Atrial Septal Defects

Clinical analysis of surgical treatment of congenital atrioventricular septal defect

Individualized application of occluder in transcatheter closure of multi-fenestrated atrial septal defects

Open heart surgery or echocardiographic transthoracic or percutaneous closure in secundum atrial septal defect: a developing approach in one Chinese hospital